CEMI-LUNG
Recruiting
500 enrolled
NIS durvalumab
Active not recruiting
250 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Recruiting
105 enrolled
MK-3475-U01
Recruiting
1,065 enrolled
ORI-EGI-03
Recruiting
450 enrolled
LUSIP
Not yet recruiting
477 enrolled
LEPIDOPTERA
Recruiting
380 enrolled
Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
Recruiting
1,000 enrolled
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled
Completed
73 enrolled 12 charts
UNCOVER
Completed
833 enrolled
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Recruiting
800 enrolled
OSIREAL
Recruiting
500 enrolled
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
Recruiting
130 enrolled
LUNG-ROLL
Recruiting
60,000 enrolled
SCLC
Completed
272 enrolled
Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations
Active not recruiting
1,500 enrolled
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Recruiting
700 enrolled
ARSENAL
Active not recruiting
254 enrolled
DP-04
Recruiting
100 enrolled
RACE-2L
Recruiting
250 enrolled
DeniLA
Recruiting
200 enrolled
Brilliant
Active not recruiting
154 enrolled
CHOICE
Not yet recruiting
590 enrolled
BASECAMP-1
Recruiting
200 enrolled
European Real-World Registry for Use of the Ion Endoluminal System
Recruiting
1,200 enrolled
CREATE
Active not recruiting
712 enrolled
NAUTIC
Recruiting
600 enrolled
Pan HER2
Not yet recruiting
2,100 enrolled
Korea Post Marketing Surveillance (PMS) Study of Vizimpro
Completed
188 enrolled
Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study
Recruiting
50 enrolled
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.
Active not recruiting
35 enrolled
AB1MALT
Active not recruiting
35 enrolled
A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery
Active not recruiting
1,200 enrolled
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
Active not recruiting
1,000 enrolled
PASSAT
Recruiting
2,000 enrolled
UmbREALung
Recruiting
300 enrolled
DREAM
Recruiting
200 enrolled
A Study in Non-Small Cell Lung Cancer
Recruiting
550 enrolled
EXoPERT EMERALD Clinical Study
Recruiting
1,400 enrolled
Australian Retrospective Analysis of EGFRm Advanced & Metastatic NSCLC Patients Treated With 1L or 2L Osimertinib.
Completed
350 enrolled
CAMPERR
Recruiting
7,000 enrolled
PTC-IMPACT
Recruiting
50 enrolled
SHIELD
Active not recruiting
12,000 enrolled
IMreal
Active not recruiting
2,756 enrolled
FOREFRONT
Active not recruiting
532 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC
Completed
70 enrolled
MAP
Not yet recruiting
3,000 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
Completed
135 enrolled